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Abstract
Background: Sex differences in pituitary growth hormone (GH) are well documented and coordinate maturation
and growth. GH and its receptor are also produced in the brain where they may impact cognitive function and
synaptic plasticity, and estradiol produces Gh sex differences in rat hippocampus. In mice, circulating estradiol
increases Gh mRNA in female but not in male medial preoptic area (mPOA); therefore, additional factors regulate
sexually dimorphic Gh expression in the brain. Thus, we hypothesized that sex chromosomes interact with estradiol
to promote sex differences in GH. Here, we assessed the contributions of both estradiol and sex chromosome
complement on Gh mRNA levels in three large brain regions: the hippocampus, hypothalamus, and cerebellum.
Methods: We used the four core genotypes (FCG) mice, which uncouple effects of sex chromosomes and gonadal
sex. The FCG model has a deletion of the sex-determining region on the Y chromosome (Sry) and transgenic
insertion of Sry on an autosome. Adult FCG mice were gonadectomized and given either a blank Silastic implant
or an implant containing 17β-estradiol. Significant differences in GH protein and mRNA were attributed to estradiol
replacement, gonadal sex, sex chromosome complement, and their interactions, which were assessed by ANOVA and
planned comparisons.
Results: Estradiol increased Gh mRNA in the cerebellum and hippocampus, regardless of sex chromosome complement
or gonadal sex. In contrast, in the hypothalamus, females had higher Gh mRNA than males, and XY females had more
Gh mRNA than XY males and XX females. This same pattern was observed for GH protein. Because the differences in Gh
mRNA in the hypothalamus did not replicate prior studies using other mouse models and tissue from mPOA or
arcuate nucleus, we examined GH protein in the arcuate, a subdivision of the hypothalamus. Like the previous
reports, and in contrast to the entire hypothalamus, a sex chromosome complement effect showed that XX mice
had more GH than XY in the arcuate.
Conclusions: Sex chromosome complement regulates GH in some but not all brain areas, and within the hypothalamus,
sex chromosomes have cell-specific actions on GH. Thus, sex chromosome complement and estradiol both
contribute to GH sex differences in the brain.
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Background
Growth hormone (GH) is synthesized in the pituitary
and the brain [1,2]. Notably, like other anterior pituitary
hormones, the secretion of GH is pulsatile and con-
trolled by metabolic and neuroendocrine mechanisms
[3-5]. There are long-established and well-documented
sex differences in the frequency and amplitude of these
GH pulses beginning during the peripubertal period in
many mammalian species, including humans [6]. GH is
also produced in the brain, where its distribution is ex-
tensive. GH receptors are present throughout the brain,
and animal and human studies have implicated central
GH signaling in neural functions [7]. For example, GH
levels influence or are correlated with cognitive perform-
ance [8] and enhance excitatory hippocampal synaptic
transmission [9]. GH also has neuroprotective effects,
protecting from age-related hippocampal deficits in plas-
ticity and learning [10] and against cerebellar damage
following ischemic injury [11]. Additionally, GH has
been broadly implicated in aging and neurogenesis, as
neural precursor cells in the subventricular zone prolif-
erate in response to central GH infusion [12]. Feeding
behavior has also been linked to GH [13], and GH ex-
pression, in the hypothalamus specifically, is associated
with sexually dimorphic body weight differences [14].
Regulation of GH differs by brain region. For example,
in the hippocampus, Gh mRNA levels are lower prior to
puberty and increased in post pubertal rats [15]. Also,
Gh mRNA and protein expression are noted in many
brain regions and known to be sexually dimorphic
(females have higher mRNA expression and protein
levels than males) in the hippocampus, preoptic area of
the hypothalamus (mPOA), and arcuate nucleus in mice
[16]. While sex differences in GH levels and release have
been documented, the mechanisms that regulate these
sex differences are not well explored.
Estradiol modulates GH protein and Gh mRNA ex-
pression in the rat hippocampus. In females, GH protein
levels in the hippocampus are highest during estrus,
when estradiol levels are elevated. In addition, ovariecto-
mized rats express low levels of Gh mRNA and protein
which increase following estradiol treatment [15]. In
mice, the arcuate nucleus and the mPOA express sexu-
ally dimorphic Gh mRNA with females having higher
levels than males. After gonadectomy, Gh mRNA de-
creases in females but not in males. Interestingly, castra-
tion actually increases Gh expression in the mPOA.
Neurons containing GH protein also contain estrogen
receptor alpha, and the anti-estrogen tamoxifen blocks
the effects of estradiol on GH in females [16]. Thus, es-
tradiol may regulate GH in females but not in males. In
addition, the numbers of X chromosomes have a direct
effect on Gh mRNA in the mouse mPOA (animals with
two X chromosomes have higher levels than those with
one X), and two genes on the X chromosome known to
escape X inactivation are correlated with Gh expression
in this region [14].
Taken together, existing data suggest that both estra-
diol and sex chromosome complement have actions on
Gh mRNA and protein in a region-specific manner in
the brain. Given the broad implications and regional
specificity of GH, its regulation is important to assess. In
this report, we tested these two factors simultaneously in
three diverse brain regions: the hypothalamus, hippo-
campus, and cerebellum. We used the four core geno-
types (FCG) mice, which have been previously utilized to
compare sex chromosome versus gonadal sex as sources
of sex differences [17,18]. In the FCG mice, gonadal sex
is unlinked from the sex chromosomes by deletion of
the sex-determining region on the Y chromosome (Sry)
and transgenic insertion of Sry on an autosome [19].
The FCG cross produces four types of offspring: normal
females with ovaries and XX chromosome genotype
(XXF), females with ovaries and XY genotype (XYF),
males with testes and XY genotype (XYM), and males
with testes and XX genotype (XX males). To manipulate
estradiol, adult gonadectomized mice were treated with
chronic implants containing estradiol or no hormone.
We report that estradiol treatment increased Gh mRNA
significantly in the hippocampus and cerebellum. Sex
chromosome complement was a factor only in the hypo-
thalamus where XY females had the highest levels of GH
protein and mRNA. Because the sex chromosome com-
plement effect was in the opposite direction from our
past reports in wild type and another sex chromosome
mutant mouse model, we quantified GH protein in the
arcuate nucleus. We replicated our previous finding that
XX mice have more GH than XY mice in the arcuate,
regardless of gonadal sex.
Methods
Animals
All procedures were approved by and conducted in ac-
cordance with the University of Virginia Animal Care
and Use Committee guidelines. The mice used for all ex-
periments were the FCG mice on a C57BL/6J back-
ground. The FCG mice are XX females, XY females, XX
males, and XY males [18]. Mice were maintained on a
12:12 light cycle (lights on at 1:00 pm). Animals had ac-
cess to water and food (# 7912 from Harlan Teklad,
Madison, WI) ad libitum.
Gonadectomy and hormone replacement
All mice between 75 and 85 days of age were gonadecto-
mized. At the time of surgery, each mouse received a
subcutaneous implant made of a 5-mm Silastic tube
(Dow Corning, Corp., Midland, MI; 1.98 mm inner
diameter × 3.18 mm outer diameter). Implants were
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either filled with 2 mg/ml 17β-estradiol benzoate in ses-
ame oil (25 μl) or empty. During the surgery, mice were
anesthetized with isoflurane. Following surgery, mice
were given 0.9% sodium chloride subcutaneously and
0.25% bupivacaine as an analgesic and individually
housed. All eight groups contained at least seven ani-
mals at the time of surgery.
Tissue collection
Animals were anesthetized with isoflurane and killed by
cervical dislocation 3 weeks after surgery. Brains were
then collected and quickly free hand dissected on ice.
The cerebellum was gently separated from the inferior
colliculi and brainstem, and the hypothalamus was re-
moved from the ventral surface of the brain by gently
separating it from the cerebral hemispheres, brainstem,
and the optic chiasm. The hippocampus was carefully
separated from the cortex, hindbrain, and diencephalon
by removing the cerebral cortex with an incision at the
end of the hemisphere and one 2 mm rostral to the first
incision. Next, the cortex was removed, which revealed
the hippocampus. All tissue was rapidly frozen following
dissection to preserve for RNA extraction. Estradiol-
implanted animals that were designated for Western
blots had the whole brain removed and rapidly frozen
on dry ice.
Quantitative real-time PCR
RNA was isolated from the brain tissue (Qiagen RNeasy
Kit), and cDNA was generated from RNA by reverse
transcription with Applied Biosciences High Capacity
cDNA Reverse Transcription Kit. Real-time PCR was
performed using the Applied Biosystems StepOne Plus
for SYBR Green-based detection with Fast SYBR® Green
Master Mix. Biological replicate samples of 5 ng were
run in triplicate, and the average was used for data ana-
lysis. Quantification of Gh (F: 5′-AGGCCCAGCAGAG
AACCGACA, R: 5′-ACGGTCCGAGGTGCCGAACA;
source sequences: AK019954, AK030419, AL604045,
BB024006, Consensus CDS: CCDS25554.1, UniProtKB/
Swiss-Prot: P06880) gene expression levels was calculated
based on the threshold cycle for each well using the pro-
vided software and normalized to B2M (F: 5′-GGCTCAC
ACTGAATTCACCCCCAC, R: 5′-ACATGTCTCGATCC
CAGTAGACGGT; source sequence: AK019389, Consen-
sus CDS: CCDS16654.1, UniProtKB/Swiss-Prot: P01887)
for hippocampus and cerebellum endogenous controls;
the endogenous control for hypothalamic tissue was Ppib
(F: 5′-TGGAGAGCACCAAGACAGACA, R: 5′-TGCC
GGAGTCGACAATGAT; source sequences: AK002357,
AL363449, CA321924, Consensus CDS: CCDS23301.1,
UniProtKB/Swiss-Prot: P24369, UniProtKB/TrEMBL:
Q9DCY1). Melting curves revealed that only one factor
per primer was amplified and that there were no
measurable primer-dimers. A no-template control was
also run to verify that amplification only occurred in
the presence of cDNA. Both B2M [20-22] and Ppib
[14,23,24] have been used as controls in qRTPCR in
our previous studies, and both B2M [25,26] and Ppib
[27,28] have been shown to be stable controls in other
work. Furthermore, there is no statistically significant
difference between groups in this study in any of the
tested brain regions in terms of the amplification time
of either endogenous control gene (data not shown).
No sex differences have been reported for these genes,
and we did not find any significant difference in the
amplification time for either control gene (data not
shown). The total number of individual cerebellum
processed was 50 (blank: XYM N = 7, XXM N = 7, XXF
N = 6, XYF N = 7; E2: XYM N = 6, XXM N = 8, XXF N = 4,
XYF N = 5). The total number of individual hippocampus
processed was 53 (blank: XYM N = 6, XXM N = 7, XXF
N = 6, XYF N = 5, E2: XYM N = 9, XXM N = 8, XXF N = 6,
XYF N = 6). The total number used for the hypothalamus
was 48 (6 per group).
Western blotting
Fresh frozen brains from estradiol-treated animals were
cut into 120-μM coronal sections in a cryostat and fro-
zen on glass microscope slides, and protein was ex-
tracted from either punch of the arcuate nucleus or
microdissected hypothalamus samples as described pre-
viously [16]. For protein extraction, tissue was thawed
and homogenized in 10 mM Tris, 400 mM Nacl, 1 mM
DTT, 1 mM EDTA, and 10% glycerol, with 10 μl/ml pro-
tease inhibitor cocktail (Sigma) and phenylmethylsulfo-
nyl fluoride (1 mM). After centrifugation, the total lysate
protein concentrations were determined by BCA protein
assay (Pierce Chemical Co., Cat# 23228.). Proteins were
separated on 14% polyacrylamide-SDS gels and trans-
ferred to nitrocellulose membranes. After transfer, mem-
branes were blocked with 5% milk and incubated with
an antibody for GH (1:5,000; National Hormone & Pep-
tide Program, CA) overnight at 4°C. After rinsing, blots
were incubated for 1 h with HRP-conjugated anti-rabbit
IgG secondary antibody (1:10,000; Vector Laboratories)
followed by detection on X-ray film (X-OMAT) with
SuperSignal West Pico Chemiluminescent Substrate
(Pierce Chemical Co.). The same blots were re-probed
with the monoclonal antibody against β-actin at 1:10,000
(Sigma-Aldrich Corp.). The intensities of GH and β-
actin bands on individual films were measured and ana-
lyzed by densitometry with ImageJ program (NIH).
Levels of GH protein were normalized to those of β-
actin in each sample, and the protein amount was
expressed as the ratio of GH to β-actin. For the hypo-
thalamus, 13 individual samples only from the estradiol-
treated groups were used (XYM N = 4, XXM N = 3, XXF
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N = 3, XYF N = 3). For the analysis of the arcuate nu-
cleus, six animals from each genotype, all estradiol
treated, were assessed.
Statistical analysis
All data were analyzed using NCSS (2001). For gene ex-
pression data, normalized gene expression was calcu-
lated using the ΔΔCt method [29]. Relative quantities
(RQs) were log transformed and analyzed by ANOVA
with sex chromosome complement, gonadal sex, and
hormone treatment as factors. For protein data, two-way
ANOVAs were used with genotype and gonadal sex as
the two factors. Significant results were assessed by Fisher’s
exact post hoc tests that adjust significance levels to take
multiple comparisons into account.
Results
Estradiol increases Gh mRNA in the hippocampus and
cerebellum
Estradiol significantly increased Gh gene expression in
both the hippocampus and cerebellum. FCG mice that
were treated with an estradiol implant at the time of
gonadectomy had higher levels of mRNA in the cere-
bellum than those that were given a blank implant
(Figure 1A; F1,49 = 8.61, P < 0.006), demonstrating for
the first time that estradiol increases Gh mRNA levels
in the cerebellum. Confirming previous results in rats
[15], estradiol-treated FCG mice had higher levels of
mRNA in the hippocampus than gonadectomized mice
without any hormone replacement (Figure 1B; F1,52 =
5.78, P < 0.03). There were no main effects of gonadal
sex and sex chromosome complement, nor were there
any significant interactions.
In the hypothalamus, gonadal sex and sex chromosome
complement modify Gh mRNA
In the hypothalamus of FCG mice, there was a main ef-
fect of gonadal sex; males had less Gh expression as
compared to females (Figure 1C; F1,47 = 4.41, P < 0.05).
An interaction between gonadal sex and sex chromo-
some complement (F1,47 = 9.21, P < 0.01) was produced
because XY female mice had higher Gh mRNA than XY
male mice (P < 0.05). Animals given estradiol implants at
the time of gonadectomy tended to have higher levels of
Figure 1 Gh mRNA in (A) the cerebellum, showing a significant increase in the relative quantity (RQ) of Gh mRNA in estradiol-treated animals of
all genotypes; (B) the hippocampus, a significant effect of estradiol on Gh RQ was noted; and (C) the hypothalamus where effects of both sex
chromosomes and gonadal sex were observed. Adult mice from the four core genotypes—XY males (black bars), XX males (horizontal striped
bars), XX females (white bars), and XY females (diagonal striped bars)—were gonadectomized and treated with estradiol (E) or given empty implants.
For the cerebellum: blank: XYM N = 7, XXM N = 7, XXF N = 6, XYF N = 7; E2: XYM N = 6, XXM N = 8, XXF N = 4, XYF N = 5. In the hippocampus: blank:
XYM N = 6, XXM N = 7, XXF N = 6, XYF N = 5; E2: XYM N = 9, XXM N = 8, XXF N = 6, XYF N = 6. In the hypothalamus: N = 6 for all groups. The single
asterisks indicate significant effect of estradiol (P < 0.05). The double asterisks indicate significant sex difference (P < 0.05). The plus symbols indicate
mice in the XY male group which are significantly different from mice in the XX male and XY female groups (P < 0.05).
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mRNA than those that were given a blank implant at the
time of gonadectomy, but this effect was not significant
(F1,47 = 2.69, P = 0.11).
Sex chromosome complement modifies GH protein in the
whole hypothalamus of estradiol-treated animals
In the hypothalamus, we noted an interaction between go-
nadal sex and sex chromosomes. Female mice had higher
Gh protein than males, and XY animals had more Gh than
XX mice (F1,13 = 20.04, P < 0.002). The amount of GH in
XY female hypothalamus tissue was significantly greater
than that in all other groups (P < 0.05). There was also a
main effect of gonadal sex wherein females had more GH
protein than males (Figure 2; F1,13 = 9.75, P < 0.02) and a
main effect of sex chromosome complement (F1,13 = 7.59,
P < 0.03) where GH levels in XY animals were greater than
in XX animals.
Sex chromosome complement modifies GH protein in the
arcuate nucleus of the hypothalamus
In the arcuate nucleus of the hypothalamus, we also noted
an effect of sex chromosomes in estradiol-treated gonad-
ectomized FCG mice (Figure 3; F1,20 = 5.45, P < 0.04). In
this nucleus, XX mice had higher levels of GH protein
than XY mice, regardless of gonadal sex (P < 0.05). No go-
nadal sex effect or interactions were present.
Discussion
Our data show that estradiol treatment increases Gh
gene expression in the cerebellum and hippocampus
with a marginal effect in the hypothalamus, and that sex
chromosome complement is correlated with Gh mRNA
in the hypothalamus. Sex chromosome complement af-
fects GH protein in the whole hypothalamus as well as
the arcuate nucleus. Previous studies conducted by our
lab showed that Gh mRNA is elevated in response to es-
tradiol in the normal C57BL/6 female mouse hypothal-
amus, but not in males [16]. In combination with the
current finding that GH protein is dependent on sex
chromosomes in the whole hypothalamus as well as the
arcuate nucleus, we suggest that estradiol and sex
chromosome genes both regulate hypothalamic Gh gene
expression.
Evidence for direct action of estradiol on GH, and fac-
tors that mediate GH release, has existed for many years.
In rats, neurons containing GH-releasing factor (GHRF)
in the hypothalamus and GH cells in the pituitary co-
express estrogen receptors [30]. In mice, agonist binding
to estrogen receptors alpha and beta induces expression
of Gh in the pituitary [31]. Moreover, estradiol increases
Gh mRNA in the mPOA and arcuate nucleus of female
mice, and the estrogen receptor antagonist tamoxifen
blocks this effect [16]. Estradiol treatment also stimu-
lates GH secretion in humans, increasing the amount of
GH per pulse twofold [4,5]. In addition, GH receptor
Figure 2 GH protein in the hypothalamus. (A) A representative blot is shown. (B) Densitometry data from the blots is presented. Adult mice
from the four core genotypes—XY males (XYM N = 4, black bars), XX males (XXM N = 3, horizontal striped bars), XX females (XXF N = 3, white
bars), and XY females (XYF N = 3, diagonal striped bars)—were gonadectomized and treated with estradiol (E). The single asterisk denotes significant
effect of sex chromosome complement (P < 0.05). The double asterisks denote significant effect of gonadal sex (P < 0.05). The plus symbol denotes XY
females which are significantly different from all other groups (P < 0.05).
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expression and GH binding increase in an estradiol-
dependent manner in rat and human bone cell lines
[32], and this relationship between estradiol and GH ex-
tends to the liver [33] and ovaries [34]. It is clear from
these previous findings, and more so now with the
addition of this study, that estradiol has an important
regulatory effect on Gh mRNA and GH protein. While a
relationship in the hypothalamus and rat hippocampus
was known, we now show that this is true in multiple
brain regions, which we expect to have widespread
implications.
Given the presence of sex differences in Gh expression
across several brain areas, we speculate that GH may
regulate sexually dimorphic processes throughout the
body. For example, Gh gene expression in the brain cor-
relates with increased food consumption and body
weight in mice [13,14] and has been implicated in feed-
ing behavior and energy homeostasis [35,14]. In a previ-
ous study using FCG mice, XY mice, independent of
gonadal sex, were more sensitive to the reward of palat-
able food intake [36], which may be representative of the
differences that we saw in GH. This would likely be due
to actions in the hypothalamus, particularly in the arcu-
ate nucleus, which has a known role in metabolism and
feeding behavior. In addition, GH deficiency has been
linked with cognitive impairment [16,35,37], and previ-
ous research has shown that Gh expression increases in
the rat hippocampus following repeated learning in re-
sponse to eye-blink conditioning [38]. In mice, infusion
of GH into the hippocampus changes expression of im-
mediate early genes and induces spontaneous locomotion,
grooming, and anxiety-like behavior [39]. Consistent with
observations in rat, our data in mice show that Gh is
expressed in the hippocampus in a hormone-dependent
manner; this may be an important aspect of learning and
memory mediation by Gh. The cerebellum is also notably
important for motor function and learning [40], and we
show that estradiol regulates Gh levels in this region too.
Pituitary GH release is sexually dimorphic [41], and
estradiol is an important activating factor in this sex dif-
ference [42]. When thinking in terms of sexual dimorph-
ism, it is imperative to consider that estradiol and other
hormones are often the only contributing element. How-
ever, steroid hormones also commonly function in con-
junction with, and in addition to, sex chromosome
complement, which is further reinforced by the data in
this study. Sex chromosome complement is an import-
ant factor for sex differences and is implicated in sexu-
ally dimorphic outcomes of aggression [43], social
interaction [43-45], and body weight [46-48]. Our data
show the significance of sex chromosome complement
for Gh gene expression and GH protein in the hypothal-
amus and the arcuate nucleus of the hypothalamus. The
use of the FCG mice in these experiments demonstrates
Figure 3 GH protein in the arcuate nucleus of the hypothalamus. (A) A representative blot is shown. (B) Densitometry data from the blots is
presented. Adult mice from the four core genotypes—XY males (black bars), XX males (horizontal striped bars), XX females (white bars), and XY
females (diagonal striped bars)—were gonadectomized and treated with estradiol (E). N = 6 in each group. The single asterisk signifies significant
effect of sex chromosome complement (P < 0.05).
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that the sex differences in these regions are not caused
exclusively by estradiol, instead suggesting that these
two principal mechanisms (estradiol and sex chromo-
somes) are acting together. We have observed a similar
interaction in previous work. An interaction between
ERα and sex chromosomes regulates calbindin gene ex-
pression in the prefrontal cortex and cerebellum of mice
[49]. Notably, Gh and calbindin are autosomal genes,
and the mechanism driving sex chromosome comple-
ment influence on autosomal gene expression is unclear.
One strong possibility is that genes on the X chromo-
some that escape X inactivation modulate autosomal
gene expression. Consistent with this proposition, Gh
expression in the POA positively correlates with the
combined levels of two X chromosome genes: Kdm5c
and Kdm6a, which encode lysine demethylases [14].
KDM5c (lysine demethylase 5c) specifically demethylates
Histone 3 Lysine 4 (H3K4) marks, acting as a transcrip-
tional repressor. KDM6a demethylates Histone 3 Lysine
27 (H3K27) and is a transcriptional activator of gene
transcription. Both Kdm5c and Kdm6a escape X inacti-
vation dosage compensation and therefore have higher
expression levels in XX females (as well as FCG XX
males) [50,51]. These X chromosome genes may modu-
late estradiol and sex chromosome actions in the
hypothalamus.
An intriguing aspect of these data is the substantial
variance in the levels of Gh mRNA and GH protein
within individuals in the genotypes that have the highest
amounts of GH. This same variability was noted in our
first two studies in normal C57BL/6 mice and in the an-
euploid Y* mutant line [16,14]. Secretion of GH from
the pituitary is pulsatile throughout the day [3-5]; there-
fore, we speculate that GH may be likewise produced
and released via an ultradian rhythm. Moreover, this hy-
pothesis suggests that GH produced in the hypothal-
amus is involved in the regulation of pituitary GH. If
such a role for neural GH exists, gene and protein ex-
pression of GH in neural cells could respond to feedback
from peripheral GH concentrations commensurate with
secretory pulsatility. The pulsatility in GH secretion
from the pituitary is sexually dimorphic, and X chromo-
some dosage may play a role in the dimorphism [41] in
addition to regulation by hormones. The mice in our
study were gonadectomized and received an estradiol or
blank implant. Thus, endogenous fluctuations of circu-
lating estradiol do not account for the individual vari-
ation we have noted both in GH protein and mRNA.
These data indicate that mRNA levels measured in the
whole hypothalamus are comparable to whole hypothal-
amic protein levels. However, the direction of the relation-
ship between amounts of GH and the sex chromosomes,
with XYF hypothalami containing the greatest amounts of
GH and message, is in stark contrast to the data we
collected in the arcuate and mPOA in normal C57BL/6
mice [8]. In that study, females (XX) had more Gh mRNA
than males (XY). In the aneuploidy (XY* model) mouse
mutant, we measured Gh mRNA in mPOA and found a
significant positive relationship between levels of Gh and
numbers of X chromosomes [9]. Thus, our protein data
from the arcuate nucleus in the FCG mice is in agreement
with the data collected in normal mice. The fact that the
entire hypothalamus and the arcuate are regulated differ-
ently by sex chromosome complement suggests cellular
differences in the transcriptional regulation of GH. Cellu-
lar phenotypes in the hypothalamus are not uniform, and
one hypothesis is that estrogen receptor alpha, which is
co-expressed in nearly all GH-positive neurons in the ar-
cuate nucleus and mPOA [16], interacts with sex chromo-
some genes that escape X inactivation.
Conclusions
We have shown that Gh gene expression is influenced
by estradiol in the cerebellum and hippocampus. In the
hypothalamus, an interaction between estradiol and sex
chromosome complement was produced by the differ-
ences in XY male and female mice, with males having
the lowest GH protein and mRNA and females having
the greatest amounts. In estradiol-treated mice, GH pro-
tein levels in the arcuate nucleus were dependent on sex
chromosome complement since XX mice of both go-
nadal sexes had higher levels than XY mice. This work
draws attention to sex differences of Gh gene expression
and GH protein in previously unexplored areas of the
brain. Future research should focus more on region-
specific roles for Gh in physiological processes and be-
havior, as well as which X chromosome genes have a
role in autosomal gene expression and how they act in
conjunction with steroid hormones.
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